Corbus Pharmaceuticals Holdings, Inc. (CRBP) Return on equity 2016–2022
Corbus Pharmaceuticals Holdings, Inc. (CRBP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-128.4%FY2022 · since FY2016: -224.2% → -128.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -128.4% | -62.3 pp |
| FY2021 | -66.0% | +179.7 pp |
| FY2020 | -245.8% | +914.7 pp |
| FY2019 | -1160.4% | -958.2 pp |
| FY2018 | -202.3% | -146.2 pp |
| FY2017 | -56.1% | +168.1 pp |
| FY2016 | -224.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice